Vitamin D, cognitive dysfunction and dementia in older adults

CNS Drugs

Volumn 25, Issue 8, 2011, Pages 629-639

  Dickens, Andy P ^a   Lang, Iain A ^a,b   Langa, Kenneth M ^c,d,e   Kos, Katarina ^a   Llewellyn, David J ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alzheimers disease; Cognition disorders; Dementia; Vitamin D deficiency.

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; 7 DEHYDROCHOLESTEROL; AMYLOID BETA PROTEIN; ANTIOXIDANT; NEUROPROTECTIVE AGENT; NITRIC OXIDE SYNTHASE; OXYGENASE; VITAMIN D; VITAMIN D RECEPTOR;

ALZHEIMER DISEASE; ANGIOCARDIOGRAPHY; APOPTOSIS; AUSTRALIA; AUTUMN; BIOAVAILABILITY; BODY MASS; BRAIN; BRAIN FUNCTION; CALCIUM ABSORPTION; CALCIUM HOMEOSTASIS; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; COGNITION; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; CYTOTOXICITY; DEMENTIA; DIABETES MELLITUS; DISEASE CLASSIFICATION; DNA POLYMORPHISM; DOWN REGULATION; EDUCATIONAL STATUS; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUP; EUROPE; FISH; FOLLOW UP; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLIA CELL; GROUPS BY AGE; HEALTH STATUS; HUMAN; HYPERTENSION; IMMUNOMODULATION; IN VITRO STUDY; ITALY; KIDNEY; LATITUDE; LEARNING DISORDER; LIQUID CHROMATOGRAPHY; LIVER; LOW DRUG DOSE; MACROPHAGE; NEOPLASM; NERVE CELL; NETHERLANDS; NEUROIMAGING; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OUTPATIENT; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BINDING; RACE; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEX; SKELETON; SKIN; SKIN CANCER; SKIN PIGMENTATION; SPRING; STROKE; SUMMER; SUN EXPOSURE; SUNLIGHT; TANDEM MASS SPECTROMETRY; TEMPERATURE; ULTRAVIOLET B RADIATION; UNITED STATES; UPREGULATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION; WHITE MATTER;

AGED; ANIMALS; CALCITRIOL; COGNITION DISORDERS; DEMENTIA; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79960802988     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.2165/11593080-000000000-00000     Document Type: Review

References (113)

1. Heaney RP, Dowell MS, Hale CA, et al. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003; 22 (2): 142-6 (Pubitemid 36417827)
2. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004 Dec; 80 (6 Suppl.): 1689S-96S
3. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a metaanalysis of randomized controlled trials. JAMA 2005; 293 (18): 2257-64 (Pubitemid 40629192)
4. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004; 291 (16): 1999-2006 (Pubitemid 38544282)
5. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167 (16): 1730-7 (Pubitemid 47403059)
6. Garland CF, Garland FC, Gorham ED, et al. The role of vitamin D in cancer prevention. Am J Public Health 2006; 96 (2): 252-61 (Pubitemid 43167123)
7. Mathieu C, Gysemans C, Giulietti A, et al. Vitamin D and diabetes. Diabetologia 2005; 48 (7): 1247-57 (Pubitemid 41186086)
8. Grandi NC, Breitling LP, Brenner H. Vitamin D and cardiovascular disease: systematic review and metaanalysis of prospective studies. Prev Med 2010; 51 (3-4): 228-33
9. Burgaz A, Orsini N, Larsson SC, et al. Blood 25-hydroxyvitamin D concentration and hypertension: a metaanalysis. J Hypertens 2011 Apr; 29 (4): 636-45
10. Anderson JL, May HT, Horne BD, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010 Oct 1; 106 (7): 963-8
11. Grant WB. Does Vitamin D reduce the risk of dementia? J Alzheimers Dis 2009; 17 (1): 151-9
12. Pogge E. Vitamin D and Alzheimer's disease: is there a link? Consult Pharm 2010 Jul; 25 (7): 440-50
13. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366 (9503): 2112-7 (Pubitemid 41797645)
14. Okura T, Plassman BL, Steffens DC, et al. Prevalence of neuropsychiatric symptoms and their association with functional limitations in older adults in the United States: the aging, demographics, and memory study. J Am Geriatr Soc 2010; 58 (2): 330-7
15. Schulz R, O'Brien AT, Bookwala J, et al. Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes. Gerontologist 1995; 35 (6): 771-91
16. Mahoney R, Regan C, Katona C, et al. Anxiety and depression in family caregivers of people with Alzheimer disease: the LASER-AD study. Am J Geriatr Psychiatry 2005; 13 (9): 795-801
17. O'Brien JT, Burns A. Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol. Epub 2010 Nov 18
18. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 2006; (1): CD005593
19. Frisardi V, Solfrizzi V, Imbimbo PB, et al. Towards disease-modifying treatment of Alzheimer's disease: drugs targeting beta-amyloid. Curr Alzheimer Res 2010 Feb; 7 (1): 40-55
20. Patterson C, Feightner JW, Garcia A, et al. Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease. Can Med Assoc J 2008; 178 (5): 548-56 (Pubitemid 351413998)
21. Barak Y, Aizenberg D. Is dementia preventable? Focus on Alzheimer's disease. Exp Rev Neurother 2010 Nov; 10 (11): 1689-98
22. Holick MF. Vitamin D deficiency. N Engl J Med 2007 Jul 19; 357 (3): 266-81
23. Eyles DW, Smith S, Kinobe R, et al. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005 Jan; 29 (1): 21-30 (Pubitemid 39602785)
24. Norval M, Wulf HC. Does chronic sunscreen use reduce vitaminDproduction to insufficient levels? Br J Dermatol 2009 Oct; 161 (4): 732-6
25. Reichrath J. Skin cancer prevention and UV-protection: how to avoid vitamin D-deficiency? Br J Dermatol 2009 Nov; 161 Suppl. 3: 54-60
26. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004 Dec; 80 (6): 1678s-88s
27. Dobbinson SJ, Wakefield MA, Jamsen KM, et al. Weekend sun protection and sunburn in Australia: trends (1987-2002) and association with SunSmart television advertising. Am J Prev Med 2008 Feb; 34 (2): 94-101
28. Moan J, Porojnicu AC, Dahlback A, et al. Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure. Proc Natl Acad Sci USA 2008 Jan 15; 105 (2): 668-73 (Pubitemid 351171766)
29. Edvardsen K, Brustad M, Engelsen O, et al. The solar UV radiation level needed for cutaneous production of vitamin D3 in the face: a study conducted among subjects living at a high latitude (68 degrees N). Photochem Photobiol Sci 2007 Jan; 6 (1): 57-62 (Pubitemid 46046006)
30. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 1988 Aug; 67 (2): 373-8
31. Gloth 3rd FM, Gundberg CM, Hollis BW, et al. Vitamin D deficiency in homebound elderly persons. JAMA 1995 Dec 6; 274 (21): 1683-6
32. Maclaughlin J, Holick MF. Aging decreases the capacity of human-skin to produce vitamin-D3. J Clin Invest 1985; 76 (4): 1536-8 (Pubitemid 16193572)
33. Holick MF, Maclaughlin JA. Aging significantly decreases the capacity of human-epidermis to produce vitamin-D3. Clin Res 1981; 29 (2): A408-A
34. Clemens TL, Adams JS, Henderson SL, et al. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1982 Jan 9; 1 (8263): 74-6 (Pubitemid 12248649)
35. Moreno-Reyes R, Carpentier YA, Boelaert M, et al. Vitamin D deficiency and hyperparathyroidism in relation to ethnicity: a cross-sectional survey in healthy adults. Eur J Nutr 2009 Feb; 48 (1): 31-7
36. Loomis WF. Skin-pigment regulation of vitamin-D biosynthesis in man. Science 1967 Aug 4; 157 (788): 501-6
37. Bogh MK, Schmedes AV, Philipsen PA, et al. Interdependence between body surface area and ultraviolet B dose in vitamin D production: a randomized controlled trial. Br J Dermatol Jan; 164 (1): 163-9
38. Hatun S, Islam O, Cizmecioglu F, et al. Subclinical vitamin D deficiency is increased in adolescent girls who wear concealing clothing. J Nutr 2005 Feb; 135 (2): 218-22 (Pubitemid 40194481)
39. Matsuoka LY, Wortsman J, Dannenberg MJ, et al. Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D3. J Clin Endocrinol Metab 1992 Oct; 75 (4): 1099-103
40. Rosen CJ. Clinical practice: vitamin D insufficiency. N Engl J Med 2011 Jan 20; 364 (3): 248-54
41. Semba RD, Houston DK, Bandinelli S, et al. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr Feb; 64 (2): 203-9
42. Evatt ML, Delong MR, Khazai N, et al. Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol 2008 Oct; 65 (10): 1348-52
43. Buell JS, Dawson-Hughes B, Scott TM, et al. 25-hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology Jan 5; 74 (1): 18-26
44. Hii S, Scherer S. Vitamin D deficiency and secondary hyperparathyroidism in older people with low trauma fractures. Aust J Ageing 2004; 23 (1): 45-7
45. Lips P. Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem 2004May; 89-90 (1-5): 611-4 (Pubitemid 38844358)
46. Souberbielle JC, Body JJ, Lappe JM, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 2010 Sep; 9 (11): 709-15
47. Llewellyn DJ, Langa KM, Lang IA. Serum 25-hydroxyvitamin D concentration and cognitive impairment. J Geriatr Psychiatry Neurol 2009; 22 (3): 188-95
48. McKenna MJ. Differences in vitamin D status between countries in young adults and the elderly. Am JMed 1992; 93 (1): 69-77
49. Lips P. Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol 2010; 121 (1-2): 297-300
50. Hirani V, Tull K, Ali A, et al. Urgent action needed to improve vitaminD status among older people in England! Age Ageing 2010; 39 (1): 62-8
51. Kuchuk NO, Pluijm SM, van Schoor NM, et al. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab 2009; 94 (4): 1244-50
52. Looker AC, Pfeiffer CM, Lacher DA, et al. Serum 25-hydroxyvitaminDstatus of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008; 88 (6): 1519-27
53. HolickMF.Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets 2011 Jan; 12 (1): 4-18
54. Kaidar-Person O, Person B, Szomstein S, et al. Nutritional deficiencies in morbidly obese patients: a new form of malnutrition? Part B: minerals. Obes Surg 2008 Aug; 18 (8): 1028-34
55. McGill AT, Stewart JM, Lithander FE, et al. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 2008; 7: 4
56. Lagunova Z, Porojnicu AC, Lindberg F, et al. The dependency of vitaminDstatus on body mass index, gender, age and season. Anticancer Res 2009 Sep; 29 (9): 3713-20
57. Heaney RP. Barriers to optimizing vitamin D3 intake for the elderly. J Nutr 2006; 136 (4): 1123-5
58. Garland CF, Gorham ED, Mohr SB, et al. Vitamin D for cancer prevention: global perspective. Ann Epidemiol 2009 Jul; 19 (7): 468-83
59. Heaney RP, Davies KM, Chen TC, et al. Human serum 25- hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003; 77 (1): 204-10 (Pubitemid 36015393)
60. Institute of Medicine. Dietary reference intakes for calcium and vitamin D: report brief. Washington, DC: National Academy of Sciences, 2010
61. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84 (1): 18-28 (Pubitemid 44699167)
62. Nimitphong H, Holick MF. Vitamin D, neurocognitive functioning and immunocompetence. Curr Opin Clin Nutr Metab Care 2011 Jan; 14 (1): 7-14
63. Heaney RP, Holick MF. Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 2011 Mar; 26 (3): 455-7
64. Hathcock JN, Shao A, Vieth R, et al. Risk assessment for vitamin D. Am J Clin Nutr 2007 Jan; 85 (1): 6-18 (Pubitemid 46067609)
65. Vieth R. Critique of the considerations for establishing the tolerable upper intake level for vitamin D: critical need for revision upwards. J Nutr 2006 Apr; 136 (4): 1117-22
66. Vieth R. Vitamin D toxicity, policy, and science. J Bone Miner Res 2007 Dec; 22 Suppl. 2: V64-8 (Pubitemid 351304652)
67. ViethR. VitaminDsupplementation, 25-hydroxyvitaminD concentrations, and safety. Am J Clin Nutr 1999 May; 69 (5): 842-56
68. Pearce SH, Cheetham TD. Diagnosis and management of vitamin D deficiency. BMJ 2010; 340: b5664
69. Stumpf WE. Drug localization and targeting with receptor microscopic autoradiography. J Pharmacol Toxicol Methods 2005 Jan-Feb; 51 (1): 25-40 (Pubitemid 41556701)
70. Fernandes de Abreu DA, Nivet E, Baril N, et al. Developmental vitamin D deficiency alters learning in C57Bl/6J mice. Behav Brain Res 2010 Apr 2; 208 (2): 603-8
71. Taghizadeh M, Djazayery A, Salami M, et al. Vitamin-Dfree regimen intensifies the spatial learning deficit in Alzheimer's disease. Int J Neurosci 2011 Jan; 121 (1): 16-24
72. Sutherland MK, Somerville MJ, Yoong LK, et al. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Brain Res Mol Brain Res 1992 Apr; 13 (3): 239-50
73. Zehnder D, Bland R, Williams MC, et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001 Feb; 86 (2): 888-94 (Pubitemid 32207511)
74. Kuningas M, Mooijaart SP, Jolles J, et al. VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiol Aging 2009; 30 (3): 466-73
75. Masoumi A, Goldenson B, Ghirmai S, et al. 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. J Alzheimers Dis 2009; 17 (3): 703-17
76. Dursun E, Gezen-Ak D, Yilmazer S. A novel perspective for Alzheimer's disease: vitamin D receptor suppression by amyloid-beta and preventing the amyloid-beta induced alterations by vitamin D in cortical neurons. J Alzheimers Dis 2010 Jan 1; 23 (2): 207-19
77. Obradovic D, Gronemeyer H, Lutz B, et al. Cross-talk of vitamin D and glucocorticoids in hippocampal cells. J Neurochem 2006 Jan; 96 (2): 500-9
78. Landfield PW, Blalock EM, Chen KC, et al. A new glucocorticoid hypothesis of brain aging: implications for Alzheimer's disease. Curr Alzheimer Res 2007 Apr; 4 (2): 205-12 (Pubitemid 46557509)
79. Fernandes de Abreu DA, Eyles D, Feron F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 2009 Dec; 34 Suppl. 1: S265-77
80. Schindowski K, BelarbiK, Buee L. Neurotrophic factors in Alzheimer's disease: role of axonal transport. Genes Brain Behav 2008 Feb; 7 Suppl. 1: 43-56
81. Taniura H, Ito M, Sanada N, et al. Chronic vitamin D3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons. J Neurosci Res 2006 May 15; 83 (7): 1179-89 (Pubitemid 43668001)
82. Lin AM, Chen KB, Chao PL. Antioxidative effect of vitaminD3 on zinc-induced oxidative stress in CNS. AnnN Y Acad Sci 2005 Aug; 1053: 319-29 (Pubitemid 43031112)
83. Garcion E, Nataf S, Berod A, et al. 1,25-dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Brain Res Mol Brain Res 1997 May; 45 (2): 255-67 (Pubitemid 27170702)
84. Austin SA, Santhanam AV, Katusic ZS. Endothelial nitric oxide modulates expression and processing of amyloid precursor protein. Circ Res 2010 Dec 10; 107 (12): 1498-502
85. Steinert JR, Chernova T, Forsythe ID. Nitric oxide signaling in brain function, dysfunction, and dementia. Neuroscientist 2010 Aug; 16 (4): 435-52
86. Veng LM, Mesches MH, Browning MD. Age-related working memory impairment is correlated with increases in the L-type calcium channel protein alpha1D (Cav1.3) in area CA1 of the hippocampus and both are ameliorated by chronic nimodipine treatment. Brain Res Mol Brain Res 2003 Feb 20; 110 (2): 193-202 (Pubitemid 36184693)
87. Mattson MP, Barger SW, Cheng B, et al. Beta-amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimers-disease. Trends Neurosci 1993 Oct; 16 (10): 409-14 (Pubitemid 23283402)
88. Schram MT, Trompet S,Kamper AM, et al. Serum calcium and cognitive function in old age. J Am Geriatr Soc 2007 Nov; 55 (11): 1786-92 (Pubitemid 350043784)
89. BrewerLD, ThibaultV,ChenKC, et al.VitaminDhormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci 2001 Jan 1; 21 (1): 98-108 (Pubitemid 32098731)
90. Brewer LD, Porter NM, Kerr DS, et al. Chronic 1alpha,25-(OH)2 vitamin D3 treatment reduces Ca2+-mediated hippocampal biomarkers of aging. Cell Calcium 2006 Sep; 40 (3): 277-86 (Pubitemid 44087863)
91. Pilz S, Dobnig H, Fischer JE, et al. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 2008 Sep; 39 (9): 2611-3
92. Oermann E, Bidmon HJ, Witte OW, et al. Effects of 1alpha, 25 dihydroxyvitamin D3 on the expression of HO-1 and GFAP in glial cells of the photothrombotically lesioned cerebral cortex. J Chem Neuroanat 2004 Dec; 28 (4): 225-38 (Pubitemid 39505283)
93. Wang Y, Chiang YH, Su TP, et al. Vitamin D-3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology 2000; 39 (5): 873-80 (Pubitemid 30103691)
94. Wolf PA. Stroke risk profiles. Stroke 2009 Mar; 40 (3 Suppl.): S73-4
95. Sato Y, Honda Y, Hayashida N, et al. Vitamin K deficiency and osteopenia in elderly women with Alzheimer's disease. Arch Phys Med Rehab 2005; 86 (3): 576-81 (Pubitemid 40326644)
96. Annweiler C, Schott AM, Allali G, et al. Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 2010; 74 (1): 27-32
97. Oudshoorn C, Mattace-Raso FU, van der Velde V, et al. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2008; 25 (6): 539-43 (Pubitemid 351957417)
98. Llewellyn DJ, Lang IA, Langa KM, et al. Vitamin D and cognitive impairment in the elderly U.S. population. J Gerontol A Biol Sci Med Sci 2011 Jan; 66 (1): 59-65
99. Buell JS, Scott TM, Dawson-Hughes B, et al. Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci 2009; 64 (8): 888-95
100. Llewellyn DJ, Lang IA, Langa KM, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 2010; 170 (13): 1135-41
101. Slinin Y, PaudelML, Taylor BC, et al. 25-hydroxyvitaminD levels and cognitive performance and decline in elderly men. Neurology 2010; 74 (1): 33-41
102. Corless D, Dawson E, Fraser F, et al. Do vitamin D supplements improve the physical capabilities of elderly hospital patients? Age Ageing 1985; 14 (2): 76-84 (Pubitemid 15131035)
103. Chandra RK. Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects. Nutrition 2001; 17 (9): 709-12 (Pubitemid 32821143)
104. Manders M, De Groot LC, Hoefnagels WH, et al. The effect of a nutrient dense drink on mental and physical function in institutionalized elderly people. J Nutr Health Aging 2009; 13 (9): 760-7
105. Meguid MM. Retraction. Nutrition 2005 Feb; 21 (2): 286
106. Lai JK, Lucas RM, ClementsMS, et al. Assessing vitamin D status: pitfalls for the unwary. Mol Nutr Food Res 2010 Aug; 54 (8): 1062-71
107. Fraser WD. Standardization of vitamin D assays: art or science? Ann Clin Biochem 2009 Jan; 46 (Pt 1): 3-4
108. Binkley N, Krueger D, Cowgill CS, et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin EndocrinolMetab 2004 Jul; 89 (7): 3152-7 (Pubitemid 38951877)
109. van den Ouweland JMW, Beijers AM, Demacker PNM, et al. Measurement of 25-OH-vitamin D in human serum using liquid chromatography tandem-mass spectrometry with comparison to radioimmunoassay and automated immunoassay. J Chromatogr B Analyt Technol Biomed Life Sci 2010 May 1; 878 (15-16): 1163-8
110. Liel Y, Ulmer E, Shary J, et al. Low circulating vitamin D in obesity. Calcif Tissue Int 1988 Oct; 43 (4): 199-201
111. McCann JC, Ames BN. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? Faseb J 2008 Apr; 22 (4): 982-1001 (Pubitemid 351519955)
112. Sato Y, Asoh T, Oizumi K. High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease. Bone 1998 Dec; 23 (6): 555-7 (Pubitemid 28529461)
113. Suzuki T, Murase S. Influence of outdoor activity and indoor activity on cognition decline: use of an infrared sensor to measure activity. Telemed J E Health 2010; 16 (6): 686-90